{"id":17823,"date":"2025-09-18T01:44:40","date_gmt":"2025-09-18T01:44:40","guid":{"rendered":"https:\/\/indiabulletinusa.com\/wordpress\/2025\/09\/18\/study-reveals-glp-1-medications-could-lower-u-s-death-rates-by-6-4\/"},"modified":"2025-09-18T01:44:40","modified_gmt":"2025-09-18T01:44:40","slug":"study-reveals-glp-1-medications-could-lower-u-s-death-rates-by-6-4","status":"publish","type":"post","link":"https:\/\/indiabulletinusa.com\/wordpress\/2025\/09\/18\/study-reveals-glp-1-medications-could-lower-u-s-death-rates-by-6-4\/","title":{"rendered":"Study Reveals GLP-1 Medications Could Lower U.S. Death Rates by 6.4%"},"content":{"rendered":"<p><br \/>\n<\/p>\n<h3>New Insights on GLP-1 Weight Loss Medications<\/h3>\n<p>A recent study shows promising results for GLP-1 drugs, originally designed for diabetes, indicating they could also lead to significant weight loss and even lower mortality rates among Americans. Researchers from Swiss Re, a reinsurance company based in Zurich, estimate that by 2045, the use of GLP-1 medications could result in a 6.4% decrease in overall death rates in the U.S. The U.K. may see a reduction of more than 5% in the same timeframe.<\/p>\n<p>Both the U.S. and U.K. have high obesity rates, with the U.S. having the highest in the world, where over 40% of adults are classified as obese. The U.K. follows with about 30% of its adult population facing obesity.<\/p>\n<p>According to experts, obesity is a major factor contributing to reduced life expectancy. It is linked to about 70% of leading causes of death in wealthier countries, such as heart disease, stroke, Alzheimer&#8217;s, and various cancers. The researchers believe that by improving foundational health risks, GLP-1 medications may ultimately save millions of lives by reducing premature deaths.<\/p>\n<p>To get the most out of GLP-1 medications, experts recommend that patients also adopt healthier lifestyle choices, including better nutrition and regular exercise. Without these changes, there\u2019s a risk of regaining weight once treatment stops.<\/p>\n<p>Paul Murray, CEO of Life &amp; Health Reinsurance at Swiss Re, remarked on the potential of GLP-1 medications to tackle the obesity epidemic effectively. He emphasized that the full benefits of these drugs will only be realized through a combination of medication, supportive policies, and lifestyle changes.<\/p>\n<p>Recent findings suggest that GLP-1 medications may also help manage other health issues beyond weight loss, providing benefits for conditions affecting the heart, kidneys, liver, skin, and even cognitive health.<\/p>\n<p>Dr. Sue Decotiis, a weight loss expert based in New York, noted that these medications can help reduce inflammation by decreasing fat cells, which can lead to a host of health improvements.<\/p>\n<p>In summary, while GLP-1 drugs like Ozempic show promise as a tool for weight loss and better health, sustainable lifestyle changes remain crucial for long-term success.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>New Insights on GLP-1 Weight Loss Medications A recent study shows promising results for GLP-1 drugs, originally designed for diabetes, indicating they could also lead to significant weight loss and even lower mortality rates among Americans. Researchers from Swiss Re, a reinsurance company based in Zurich, estimate that by 2045, the use of GLP-1 medications<\/p>\n","protected":false},"author":1,"featured_media":17824,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[32],"tags":[1990,18808,19,18662,18595,18721,3530,18720],"class_list":["post-17823","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-healthy-living","tag-lifestyle","tag-longevity","tag-medical-research","tag-medications","tag-obesity","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/17823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/comments?post=17823"}],"version-history":[{"count":0,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/17823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media\/17824"}],"wp:attachment":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media?parent=17823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/categories?post=17823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/tags?post=17823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}